Delivery Order 75N94020D00004-75N94020F00001
Award Date
8/1/20
Potential Completion Date
7/31/27
Potential Value
$101K
Federal Agency
National Institute of Child Health and Human Development
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Boston, MA 02118, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
18
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Boston Medical Center Corporation is providing clinical trial network services under a $678,333 delivery order against the Contraceptive Clinical Trials Network-Female Sites contract vehicle through the National Institutes of Health National Institute of Child Health and Human Development. As the prime contractor, BMC will support the Evaluation of LARCs Study as a clinical research site. No set-aside designation was applied to this order to evaluate long-acting reversible contraceptive methods....
Boston Medical Center Corporation was awarded a $108,311.84 cost-no-fee delivery order against the Contraceptive Clinical Trials Network-Female Sites contract vehicle by the Department of Health and Human Services' National Institutes of Health National Institute of Child Health and Human Development. This delivery order calls for BMC to provide assistance in protocol review, protocol development, and other activities associated with the past, present, and future of the Contraceptive Clinical...
This federal contract award is for the Contraceptive Clinical Trials Network - Female Sites Evaluation of LARCs Study, awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Boston Medical Center Corporation (BMC). The $639,028.72 cost-reimbursement contract has an ultimate completion date of July 14, 2026. BMC, a major safety-net hospital and academic medical center, will provide services related to the Contraceptive Clinical Trials Network, which...
This is a Delivery Order under Contract 75N94020D00004 awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Boston Medical Center Corporation (BMC) for a clinical trial of the OVAPRENE vaginal device. The award has a ceiling value of $126,095 and a period of performance through November 30, 2025. The contract is for TASK ORDER 2: OVAPRENE PHASE 1 - PROTOCOL FINALIZATION, PROCUREMENT OF REGULATORY APPR. BMC is a major safety-net hospital and...
The Centers for Disease Control and Prevention (CDC) awarded a $912,168 delivery order contract to Boston Medical Center Corporation (BMC) to provide Clinical Immunization Safety Assessment (CISA) services from September 2023 through September 2026. This work supports the Department of Health and Human Services' immunization safety programs. BMC is a major safety-net hospital and academic medical center in Boston that conducts extensive biomedical and clinical research, participates in public...
This is a $15,589.93 firm-fixed-price delivery order awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services (HHS), to Boston Medical Center Corporation (BMC), a non-profit academic medical center in Boston, Massachusetts. The contract is for CPTAC (Clinical Proteomic Tumor Analysis Consortium) task order services and does not have a set-aside designation. The order is part of a larger NCI Tissue Source Site for Tumor Analysis indefinite...
This is a federal contract award to Boston Medical Center Corporation (BMC), a major safety-net hospital and academic medical center in Boston, Massachusetts. The contract was awarded by the Centers for Disease Control and Prevention (CDC) to provide Clinical Immunization Safety Assessment (CISA) services. The contract is a $742,721 delivery order under the CISA master IDIQ contract, which has a ceiling value of $86 million and runs from 2023 to 2028. The contract is not set aside. BMC is a...
This federal contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Boston Medical Center Corporation (BMC), a private, not-for-profit academic medical center. The contract is a Delivery Order under the Clinical Immunization Safety Assessment (CISA) Master IDIQ, with a potential value of $728,754.00. BMC has provided clinical immunization safety assessment services to support the Department of Health and Human Services' immunization...
The Centers for Disease Control and Prevention (CDC) awarded Boston Medical Center Corporation (BMC), a private, not-for-profit academic medical center, a $759,826 delivery order contract to provide Clinical Immunization Safety Assessment (CISA) services in support of the Department of Health and Human Services (HHS) program activities from 2023 to 2028. This award is part of a larger CISA indefinite delivery contract with a potential value of $86 million. BMC has a history of providing services...
This federal contract award, valued at $655,019.75, was issued by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services (HHS). The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the University of Cincinnati to conduct clinical evaluation of novel female contraceptive products through a Contraceptive Clinical Trial Network. The award facilitates pilot and efficacy studies,...